Global Guidelines on Protection of Vulnerable Participants in Clinical Trials
Global Guidelines on Protection of Vulnerable Participants in Clinical Trials International Guidelines for Protecting Vulnerable Participants in Clinical Trials Vulnerable participants in clinical research—including children, cognitively impaired individuals, economically disadvantaged populations, and marginalized communities—require additional ethical and regulatory protections. International organizations such as the USFDA, EMA, CDSCO, WHO, and ICH provide clear guidance on how…
Read More “Global Guidelines on Protection of Vulnerable Participants in Clinical Trials” »